Literature DB >> 16478751

Enhanced stability of recombinant keratinocyte growth factor by mutagenesis.

Eric Hsu1, Timothy Osslund, Rebecca Nybo, Bao-Lu Chen, William C Kenney, C Fred Morris, Tsutomu Arakawa, Linda O Narhi.   

Abstract

Native sequence keratinocyte growth factor (KGF) is fairly unstable, as manifested by the loss of the monomeric native protein accompanied by the accumulation of aggregated species during storage at moderate temperatures. Several different types of analogs were generated and the storage stability of the protein assessed. In the first type of analog one or more of the five cysteinyl residues in KGF were replaced; in the second class the N-terminal residues that included the first disulfide bond were deleted. Both of these types of analogs involved removal of the disulfide bond between cysteines 1 and 15. The third group involved mutating one of the basic amino acids located in a cluster of positive charges (involved in heparin binding) around Arg144 to a neutral or acidic amino acyl residue. Among the cysteine replacement analogs, the double mutation of Cys1 and 15 to Ser resulted in significantly increased stability without compromising the mitogenic activity, while Cys to Ser mutations at other positions were either destabilizing or had no effect. Deletion of the 15, 23 or 27 N-terminal amino acyl residues also increased the stability of the protein. The activity of the analogs was not affected by the deletion of 15 or 23 amino acids, but it was significantly decreased upon removal of the 27 N-terminal amino acyl residues. Much greater stability was achieved by mutation of the basic amino acids, especially Arg144, to Glu or Gln, but this increase in stability was accompanied by large decrease in activity. The analog with the 23 N-terminal amino acyl residues deleted represents one of the best compromises between increased stability and retention of activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478751     DOI: 10.1093/protein/gzj013

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  9 in total

1.  Keratinocyte growth factor improves repair in the injured tracheal epithelium.

Authors:  Brigitte N Gomperts; John A Belperio; Michael C Fishbein; Michael P Keane; Marie D Burdick; Robert M Strieter
Journal:  Am J Respir Cell Mol Biol       Date:  2007-03-01       Impact factor: 6.914

2.  Keratinocyte growth factor protects against Clara cell injury induced by naphthalene.

Authors:  A O Yildirim; M Veith; T Rausch; B Müller; P Kilb; L S Van Winkle; H Fehrenbach
Journal:  Eur Respir J       Date:  2008-04-02       Impact factor: 16.671

3.  Treatment with keratinocyte growth factor does not improve lung allograft survival in the rat.

Authors:  Markus Hirschburger; Martin Obert; Horst Traupe; Tim Kuchenbuch; Winfried Padberg; Heinz Fehrenbach; Veronika Grau
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

4.  Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.

Authors:  K Brookes; J Cummings; A Backen; A Greystoke; T Ward; G C Jayson; C Dive
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

5.  Differential orientation and conformation of surface-bound keratinocyte growth factor on (hydroxyethyl)methacrylate, (hydroxyethyl)methacrylate/methyl methacrylate, and (hydroxyethyl)methacrylate/methacrylic acid hydrogel copolymers.

Authors:  Shohini Sen-Britain; Wesley L Hicks; Robert Hard; Joseph A Gardella
Journal:  Biointerphases       Date:  2018-10-25       Impact factor: 2.456

6.  Post-production protein stability: trouble beyond the cell factory.

Authors:  Esther Vazquez; José Luis Corchero; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2011-08-01       Impact factor: 5.328

Review 7.  Engineering of therapeutic proteins production in Escherichia coli.

Authors:  Mariusz Kamionka
Journal:  Curr Pharm Biotechnol       Date:  2011-02-01       Impact factor: 2.837

8.  Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury.

Authors:  Gerardo M Castillo; Akiko Nishimoto-Ashfield; Cynthia C Jones; Kasim K Kabirov; Alexander Zakharov; Alexander V Lyubimov
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

9.  A novel solid-phase site-specific PEGylation enhances the in vitro and in vivo biostabilty of recombinant human keratinocyte growth factor 1.

Authors:  Zhifeng Huang; Guanghui Zhu; Chuanchuan Sun; Jingui Zhang; Yi Zhang; Youting Zhang; Chaohui Ye; Xiaojie Wang; Dariush Ilghari; Xiaokun Li
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.